{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:27:50Z","timestamp":1783391270569,"version":"3.54.6"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.hpb.2025.03.003","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:10:52Z","timestamp":1741752652000},"page":"746-757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["\u201cSomatostatin analogues do not reduce the risk of clinically relevant post-operative fistula rates in patients undergoing pancreatic surgery\u201d, a systematic review and meta-analysis"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9320-1586","authenticated-orcid":false,"given":"Carolyn","family":"Cullinane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4976-4733","authenticated-orcid":false,"given":"Michael","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alazzawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Criostoir O.","family":"Suilleabhain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian O.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2025.03.003_bib1","first-page":"7","article-title":"Cancer statistics","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hpb.2025.03.003_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.mpa.0000229010.62538.f2","article-title":"Pancreatic cancer: from bench to 5-year survival","volume":"33","author":"Kleeff","year":"2006","journal-title":"Pancreas"},{"key":"10.1016\/j.hpb.2025.03.003_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.sla.0000217673.04165.ea","article-title":"One thousand consecutive pancreaticoduodenectomies","volume":"244","author":"Cameron","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archsurg.136.4.391","article-title":"Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization","volume":"136","author":"Balcom","year":"2001","journal-title":"Arch Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib5","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.3390\/jcm9092766","article-title":"Predictive factors associated with complications after laparoscopic distal pancreatectomy","volume":"9","author":"Song","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.hpb.2025.03.003_bib6","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.surg.2021.04.023","article-title":"Evidence map of pancreatic surgery-A living systematic review with meta-analyses by the international study group of pancreatic surgery (ISGPS)","volume":"170","author":"Probst","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2025.03.003_bib7","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.hpb.2019.06.004","article-title":"Pre-, peri- and post-operative factors for the development of pancreatic fistula after pancreatic surgery","volume":"21","author":"S\u00f8reide","year":"2019","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2025.03.003_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006858","article-title":"Pancreatoduodenectomy (PD) and postoperative pancreatic fistula (POPF): a systematic review and analysis of the POPF-related mortality rate in 60,739 patients retrieved from the English literature published between 1990 and 2015","volume":"96","author":"Pedrazzoli","year":"2017","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.hpb.2025.03.003_bib9","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/bjs.1800820938","article-title":"Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis","volume":"82","author":"Friess","year":"1995","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0039-6060(05)80225-9","article-title":"Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial","volume":"117","author":"Montorsi","year":"1995","journal-title":"Surgery"},{"issue":"3 Suppl","key":"10.1016\/j.hpb.2025.03.003_bib11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1136\/gut.35.3_Suppl.S1","article-title":"Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects","volume":"35","author":"Harris","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.hpb.2025.03.003_bib12","article-title":"Somatostatin analogues for pancreatic surgery","volume":"2013","author":"Gurusamy","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hpb.2025.03.003_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0002-9610(92)90264-R","article-title":"Role of octreotide in the prevention of postoperative complications following pancreatic resection","volume":"163","author":"B\u00fcchler","year":"1992","journal-title":"Am J Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00000658-199711000-00008","article-title":"Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease","volume":"226","author":"Lowy","year":"1997","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.surg.2005.05.001","article-title":"International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition","volume":"138","author":"Bassi","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2025.03.003_bib16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMc1407470","article-title":"Pasireotide for postoperative pancreatic fistula","volume":"371","author":"Allen","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hpb.2025.03.003_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jamcollsurg.2017.10.021","article-title":"Prospective evaluation of pasireotide in patients undergoing pancreaticoduodenectomy: the Washington university experience","volume":"226","author":"Dominguez-Rosado","year":"2018","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.hpb.2017.10.018","article-title":"Pasireotide does not prevent postoperative pancreatic fistula: a prospective study","volume":"20","author":"Elliott","year":"2018","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2025.03.003_bib19","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s11605-019-04479-4","article-title":"Efficacy of pasireotide for prevention of postoperative pancreatic fistula in pancreatic surgery: a systematic review and meta-analysis","volume":"24","author":"Liu","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188928","article-title":"The effect of somatostatin analogues on postoperative outcomes following pancreatic surgery: a meta-analysis","volume":"12","author":"Han","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2025.03.003_bib21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pan.2019.12.015","article-title":"Somatostatin analogues and the risk of post-operative pancreatic fistulas after pancreatic resection - a systematic review & meta-analysis","volume":"20","author":"Li","year":"2020","journal-title":"Pancreatology"},{"key":"10.1016\/j.hpb.2025.03.003_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017196","article-title":"An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection","volume":"98","author":"Zheng","year":"2019","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.hpb.2025.03.003_bib23","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1477-2574.2012.00608.x","article-title":"Prospective randomized trial of the effect of octreotide on pancreatic juice output after pancreaticoduodenectomy in relation to histological diagnosis, duct size and leakage","volume":"15","author":"Fern\u00e1ndez-Cruz","year":"2013","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2025.03.003_bib24","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.surg.2016.11.014","article-title":"International study group on pancreatic surgery (ISGPS). The 2016 update of the international study group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years after","volume":"161","author":"Bassi","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2025.03.003_bib25","author":"Wells"},{"key":"10.1016\/j.hpb.2025.03.003_bib26","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa1313688","article-title":"Pasireotide for postoperative pancreatic fistula","volume":"370","author":"Allen","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hpb.2025.03.003_bib27","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1007\/s00268-014-2512-4","article-title":"A cost analysis of somatostatin use in the prevention of pancreatic fistula after pancreatectomy","volume":"38","author":"Anderson","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.pan.2022.03.006","article-title":"Dutch Pancreatic Cancer Group. Somatostatin analogues for the prevention of pancreatic fistula after open pancreatoduodenectomy: a nationwide analysis","volume":"22","author":"Bootsma","year":"2022","journal-title":"Pancreatology"},{"key":"10.1016\/j.hpb.2025.03.003_bib29","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s00535-021-01818-8","article-title":"A randomised, multicentre trial of somatostatin to prevent clinically relevant postoperative pancreatic fistula in intermediate-risk patients after pancreaticoduodenectomy","volume":"56","author":"Cao","year":"2021","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.hpb.2025.03.003_bib30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1477-2574.2012.00608.x","article-title":"Prospective randomized trial of the effect of octreotide on pancreatic juice output after pancreaticoduodenectomy in relation to histological diagnosis, duct size and leakage","volume":"15","author":"Fern\u00e1ndez-Cruz","year":"2013","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2025.03.003_bib31","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s00595-020-02189-y","article-title":"Somatostatin administration following pancreatoduodenectomy: a case-matched comparison according to surgical technique, body mass index, American Society of Anesthesiologists\u2019 score and Fistula Risk Score","volume":"51","author":"Furbetta","year":"2021","journal-title":"Surg Today"},{"key":"10.1016\/j.hpb.2025.03.003_bib32","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00268-005-7546-1","article-title":"Prospectively randomized trial using perioperative low-dose octreotide to prevent organ-related and general complications after pancreatic surgery and pancreatico-jejunostomy","volume":"29","author":"Hesse","year":"2005","journal-title":"World J Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib33","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ejso.2008.01.014","article-title":"Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial","volume":"34","author":"Kollmar","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2025.03.003_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jamcollsurg.2018.10.018","article-title":"Outcomes after pancreatectomy with routine pasireotide use","volume":"228","author":"Kunstman","year":"2019","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib35","first-page":"179","article-title":"The role of somatostatin in 67 consecutive pancreatectomies: a randomized clinical trial","volume":"3","author":"Katsourakis","year":"2010","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.hpb.2025.03.003_bib36","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s11605-015-2925-x","article-title":"Octreotide does not prevent pancreatic fistula following pancreatoduodenectomy in patients with soft pancreas and non-dilated duct: a prospective randomized controlled trial","volume":"19","author":"Kurumboor","year":"2015","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib37","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/hpb.12314","article-title":"Prophylactic octreotide for pancreatoduodenectomy: more harm than good?","volume":"16","author":"McMillan","year":"2014","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2025.03.003_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.hbpd.2018.01.015","article-title":"Efficacy of octreotide in the prevention of complications after pancreaticoduodenectomy in patients with soft pancreas and non-dilated pancreatic duct: a prospective randomized trial","volume":"17","author":"El Nakeeb","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hpb.2025.03.003_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jso.25949","article-title":"Risk-stratified analysis of pasireotide for patients undergoing pancreatectomy","volume":"122","author":"Peng","year":"2020","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.hpb.2025.03.003_bib40","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.pan.2020.03.010","article-title":"Pasireotide administration after pancreaticoduodenectomy may decrease clinically relevant postoperative pancreatic fistula in high-risk patients with small pancreatic ducts, soft pancreatic parenchyma and cystic or neuroendocrine neoplasia","volume":"20","author":"Vuorela","year":"2020","journal-title":"Pancreatology"},{"key":"10.1016\/j.hpb.2025.03.003_bib41","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029303","article-title":"Prophylactic octreotide for postoperative pancreatic fistula in patients with pancreatoduodenectomy: risk-stratified analysis","volume":"101","author":"Yoon","year":"2022","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.hpb.2025.03.003_bib42","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.asjsur.2018.08.006","article-title":"Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy","volume":"42","author":"You","year":"2019","journal-title":"Asian J Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib43","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.hpb.2018.03.007","article-title":"Pasireotide is not effective in reducing the development of postoperative pancreatic fistula","volume":"20","author":"Young","year":"2018","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2025.03.003_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"Cochrane bias methods group; cochrane statistical methods group. The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.hpb.2025.03.003_bib45","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000381032","article-title":"Systematic review and meta-analysis of somatostatin analogues in the prevention of postoperative complication after pancreaticoduodenectomy","volume":"32","author":"Jin","year":"2015","journal-title":"Dig Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib46","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s11605-011-1726-0","article-title":"Clinical validation of the ISGPF classification and the risk factors of pancreatic fistula formation following duct-to-mucosa pancreaticojejunostomy by one surgeon at a single center","volume":"15","author":"Kim","year":"2011","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/SLA.0000000000001537","article-title":"Risk-adjusted outcomes of clinically relevant pancreatic fistula following pancreatoduodenectomy: a model for performance evaluation","volume":"264","author":"McMillan","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib48","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000129423","article-title":"Effect of octreotide acetate on pancreatic exocrine and endocrine functions after pancreatoduodenal resection","volume":"27","author":"Petrin","year":"1995","journal-title":"Eur Surg Res"},{"issue":"3 Suppl","key":"10.1016\/j.hpb.2025.03.003_bib49","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1136\/gut.35.3_Suppl.S20","article-title":"Role of somatostatin and somatostatin analogues in the treatment of gastrointestinal diseases: prevention of complications after pancreatic surgery","volume":"35","author":"Bassi","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.hpb.2025.03.003_bib50","first-page":"427","article-title":"Prevention of postoperative pancreatic complications following duodenopancreatectomy using somatostatin","volume":"50","author":"Klempa","year":"1979","journal-title":"Chirurg"},{"key":"10.1016\/j.hpb.2025.03.003_bib51","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00268-003-6693-5","article-title":"Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial","volume":"27","author":"Shan","year":"2003","journal-title":"World J Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib52","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1046\/j.0007-1323.2001.01906.x","article-title":"Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy","volume":"88","author":"Gouillat","year":"2001","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib53","first-page":"221","article-title":"Profilaxis con Somatostatina tras duodenopancreatectom\u00eda cef\u00e1lica [Somatostatin prophylaxis following cephalic duodenopancreatectomy]","volume":"87","author":"Beguiristain","year":"1995","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.hpb.2025.03.003_bib54","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1667\/RR1685.1","article-title":"The somatostatin analog SOM230 (pasireotide) ameliorates injury of the intestinal mucosa and increases survival after total-body irradiation by inhibiting exocrine pancreatic secretion","volume":"171","author":"Fu","year":"2009","journal-title":"Radiat Res"},{"key":"10.1016\/j.hpb.2025.03.003_bib55","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1530\/eje.0.1460707","article-title":"SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile","volume":"146","author":"Bruns","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.hpb.2025.03.003_bib56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/SLA.0000000000001975","article-title":"Invited commentary: pasireotide and the prevention of pancreatic fistula after pancreatectomy: \u201cthe continued search for harry potter\u2019s liquid luck\u201d","volume":"265","author":"Yeo","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jamcollsurg.2012.09.002","article-title":"A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy","volume":"216","author":"Callery","year":"2013","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib58","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1091-255X(00)80105-5","article-title":"Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators","volume":"4","author":"Sohn","year":"2000","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib59","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.surg.2016.11.021","article-title":"Pancreatic anastomosis after pancreatoduodenectomy: a position statement by the international study group of pancreatic surgery (ISGPS)","volume":"161","author":"Shrikhande","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2025.03.003_bib60","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00423-016-1502-4","article-title":"Perioperative application of somatostatin analogs for pancreatic surgery-current status in Germany","volume":"401","author":"Volk","year":"2016","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib61","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00423-016-1456-6","article-title":"Cost-effectiveness comparison of prophylactic octreotide and pasireotide for prevention of fistula after pancreatic surgery","volume":"401","author":"Welsch","year":"2016","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib62","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/SLA.0000000000006313","article-title":"Collaborators. Somatostatin versus octreotide for prevention of postoperative pancreatic fistula: the PREFIPS randomized clinical trial: a FRENCH 007-ACHBT study","volume":"280","author":"Gaujoux","year":"2024","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.03.003_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002742","article-title":"COSMOS-E: guidance on conducting systematic reviews and meta-analyses of observational studies of etiology","volume":"16","author":"Dekkers","year":"2019","journal-title":"PLoS Med"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X25000784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X25000784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T01:39:47Z","timestamp":1780277987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X25000784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1365182X25000784"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2025.03.003","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cSomatostatin analogues do not reduce the risk of clinically relevant post-operative fistula rates in patients undergoing pancreatic surgery\u201d, a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2025.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}